Cargando…

Torasemide Improves the Propionic Acid-Induced Autism in Rats: A Histopathological and Imaging Study

OBJECTIVE: Autism spectrum disorder is a neurodevelopmental disease in which impaired social behaviors, impaired sociality, and restricted and repetitive behaviors are seen. Bumetanide is a loop diuretic that inhibits Na(+)–K(+)–2Cl(−) cotransporter 1 and it is currently used in clinical phase studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Doğan, Murat, Albayrak, Yakup, Erbaş, Oytun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVES 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984905/
https://www.ncbi.nlm.nih.gov/pubmed/36879996
http://dx.doi.org/10.5152/alphapsychiatry.2023.22975
_version_ 1784900835894886400
author Doğan, Murat
Albayrak, Yakup
Erbaş, Oytun
author_facet Doğan, Murat
Albayrak, Yakup
Erbaş, Oytun
author_sort Doğan, Murat
collection PubMed
description OBJECTIVE: Autism spectrum disorder is a neurodevelopmental disease in which impaired social behaviors, impaired sociality, and restricted and repetitive behaviors are seen. Bumetanide is a loop diuretic that inhibits Na(+)–K(+)–2Cl(−) cotransporter 1 and it is currently used in clinical phase studies in patients with autism spectrum disorder. In present research, it is purposed to demonstrate the beneficial effects of torasemide which is another Na(+)–K(+)–2Cl(−) cotransporter 1 inhibitor on an experimental autism model induced with propionic acid by providing imaging and brain tissue investigations. METHODS: Male Wistar rats were used in the present study (n = 30). Propionic acid of 250 mg/kg/day was administrated intraperitoneally in rats to induce autism for 5 days. Three groups were created for present study as follows: group 1, normal control (n = 10); group 2, propionic acid and saline given group (n = 10); group 3, propionic acid + tora-semide-administrated group (n = 10). RESULTS: Torasemide group scored higher on behavioral tests compared to saline group. The brain levels of malondialdehyde, tumor necrosis factor-alpha, interleukin-2, interleukin-17, and Nuclear Factor kappa B (NF-κB), Glial fibrillary acidic protein (GFAP) were remarkably higher in propionic acid + saline group. In histopathology assessments, torasemide group had higher neuronal count of Cornu Ammonis 1, neuronal count of Cornu Ammonis 2 in hippocampus, and Purkinje cells in cerebellum. GFAP immunostaining index (Cornu Ammonis 1) and cerebellum were lower in torasemide group. Magnetic resonance spectroscopy revealed that mean lactate value was higher in propionic acid + saline group compared to torasemide group. CONCLUSION: Our experimental results showed that torasemide might enhance gamma-aminobutyric acid activity. Torasemide can be considered another promising Na(+)–K(+)–2Cl(−) cotransporter 1 inhibitor in the treatment of autism with a longer half-life and less side effects after further studies.
format Online
Article
Text
id pubmed-9984905
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AVES
record_format MEDLINE/PubMed
spelling pubmed-99849052023-03-05 Torasemide Improves the Propionic Acid-Induced Autism in Rats: A Histopathological and Imaging Study Doğan, Murat Albayrak, Yakup Erbaş, Oytun Alpha Psychiatry Original Article OBJECTIVE: Autism spectrum disorder is a neurodevelopmental disease in which impaired social behaviors, impaired sociality, and restricted and repetitive behaviors are seen. Bumetanide is a loop diuretic that inhibits Na(+)–K(+)–2Cl(−) cotransporter 1 and it is currently used in clinical phase studies in patients with autism spectrum disorder. In present research, it is purposed to demonstrate the beneficial effects of torasemide which is another Na(+)–K(+)–2Cl(−) cotransporter 1 inhibitor on an experimental autism model induced with propionic acid by providing imaging and brain tissue investigations. METHODS: Male Wistar rats were used in the present study (n = 30). Propionic acid of 250 mg/kg/day was administrated intraperitoneally in rats to induce autism for 5 days. Three groups were created for present study as follows: group 1, normal control (n = 10); group 2, propionic acid and saline given group (n = 10); group 3, propionic acid + tora-semide-administrated group (n = 10). RESULTS: Torasemide group scored higher on behavioral tests compared to saline group. The brain levels of malondialdehyde, tumor necrosis factor-alpha, interleukin-2, interleukin-17, and Nuclear Factor kappa B (NF-κB), Glial fibrillary acidic protein (GFAP) were remarkably higher in propionic acid + saline group. In histopathology assessments, torasemide group had higher neuronal count of Cornu Ammonis 1, neuronal count of Cornu Ammonis 2 in hippocampus, and Purkinje cells in cerebellum. GFAP immunostaining index (Cornu Ammonis 1) and cerebellum were lower in torasemide group. Magnetic resonance spectroscopy revealed that mean lactate value was higher in propionic acid + saline group compared to torasemide group. CONCLUSION: Our experimental results showed that torasemide might enhance gamma-aminobutyric acid activity. Torasemide can be considered another promising Na(+)–K(+)–2Cl(−) cotransporter 1 inhibitor in the treatment of autism with a longer half-life and less side effects after further studies. AVES 2023-01-01 /pmc/articles/PMC9984905/ /pubmed/36879996 http://dx.doi.org/10.5152/alphapsychiatry.2023.22975 Text en 2023 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Article
Doğan, Murat
Albayrak, Yakup
Erbaş, Oytun
Torasemide Improves the Propionic Acid-Induced Autism in Rats: A Histopathological and Imaging Study
title Torasemide Improves the Propionic Acid-Induced Autism in Rats: A Histopathological and Imaging Study
title_full Torasemide Improves the Propionic Acid-Induced Autism in Rats: A Histopathological and Imaging Study
title_fullStr Torasemide Improves the Propionic Acid-Induced Autism in Rats: A Histopathological and Imaging Study
title_full_unstemmed Torasemide Improves the Propionic Acid-Induced Autism in Rats: A Histopathological and Imaging Study
title_short Torasemide Improves the Propionic Acid-Induced Autism in Rats: A Histopathological and Imaging Study
title_sort torasemide improves the propionic acid-induced autism in rats: a histopathological and imaging study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984905/
https://www.ncbi.nlm.nih.gov/pubmed/36879996
http://dx.doi.org/10.5152/alphapsychiatry.2023.22975
work_keys_str_mv AT doganmurat torasemideimprovesthepropionicacidinducedautisminratsahistopathologicalandimagingstudy
AT albayrakyakup torasemideimprovesthepropionicacidinducedautisminratsahistopathologicalandimagingstudy
AT erbasoytun torasemideimprovesthepropionicacidinducedautisminratsahistopathologicalandimagingstudy